-
MED12L Gene Alterations Define Aggressive BRCA2-Mutant Prostate Cancers
Study
EGAS00001001615
-
Melanoma_C32_ENU_Resistance_to_Single_Agent_Therapy
Study
EGAS00001001697
-
Whole genome sequencing and whole exome sequencing of mucosal melanoma
Study
EGAS00001000474
-
Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma
Study
EGAS00001001665
-
Clonal_expansion_of_mutated_cell_population_in_bladder_urothelium_
Study
EGAS00001001687
-
Automated system for scoring hematoxylin and eosin-stained ovarian cancer sections by identifying single cells uncovered that stromal cell ratio is a significant predictor for overall survival and progression-free survival.
Study
EGAS00001001694
-
Copy number profiling of primary samples and cell lines of retinoblastoma
Study
EGAS00001001715
-
Linking genes, genomic instability and molecular subgroups in medulloblastoma
Study
EGAS00001000085
-
Pharmacogenomic landscape of patient-derived cells informs precision oncology therapy
Study
EGAS00001002515
-
Somatic_Variation_Angiosarcoma
Study
EGAS00001002610